about
Impact of Ho(3+)-doping on (13)C dynamic nuclear polarization using trityl OX063 free radicalAnalysis of Lanthanide Complex Dendrimer Conjugates for Bimodal NIR and MRI Imaging.Encapsulated gadolinium and dysprosium ions within ultra-short carbon nanotubes for MR microscopy at 11.75 and 21.1 T.Gadolinium oxysulfide nanoparticles as multimodal imaging agents for T2-weighted MR, X-ray tomography and photoluminescence.Dysprosium-Modified Tobacco Mosaic Virus Nanoparticles for Ultra-High-Field Magnetic Resonance and Near-Infrared Fluorescence Imaging of Prostate Cancer.Semiempirical quantum chemistry model for the lanthanides: RM1 (Recife Model 1) parameters for dysprosium, holmium and erbium.Quantitative interpretation of the very fast electronic relaxation of most Ln3+ ions in dissolved complexes.Engineering of inorganic nanoparticles as magnetic resonance imaging contrast agents.Upconversion of Ln3+-based Nanoparticles for Optical Bio-imagingHybrid lanthanide nanoparticles as a new class of binary contrast agents for in vivo T1/T2 dual-weighted MRI and synergistic tumor diagnosisMicrowave-Assisted Seeded Growth of Lanthanide-Based Nanoparticles for Imaging and TherapySilica Nanoparticles for Bimodal MRI-Optical Imaging by Grafting Gd3+ and Eu3+/Tb3+ ComplexesMultifunctional β-NaGdF4:Ln3+ (Ln = Yb, Er, Dy) nanoparticles with NIR to visible upconversion and high transverse relaxivity: a potential bimodal contrast agent for high-field MRI and optical imaging
P2860
Q31115261-BF9182D1-CB9B-4EFA-A020-1EEA589EBB08Q36443368-51AC6105-B052-441A-BE3E-F677E4F74344Q39029771-0275489B-3EDF-4690-84FC-F33BAEFAC424Q39062309-9DBD4B76-9F97-4E9C-92EA-18AF68CE23C6Q40063129-BC1D8F59-BD1E-4579-AFD4-20C53C7E27AFQ41904003-486F64C6-AC70-41CB-BE01-F2859FDE41EAQ46388731-B872CC83-C6E1-4048-8770-2C4D69ABC948Q47409412-22F7949C-2B98-4DE3-8D4B-71666A7C6877Q57340472-C488C572-471A-4F5A-8EDE-9E30C0FF5827Q57377086-67B92C85-12A0-4E62-91DB-13D7589554DDQ57391318-462FCDF4-871F-4410-B309-A1509FB46CA3Q57651288-709B16AB-9C12-444C-BEDF-ACE43BB833B3Q58281628-FFC1A43D-0C09-454A-BE72-BA775300DBFD
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MRI contrast agents based on dysprosium or holmium.
@en
MRI contrast agents based on dysprosium or holmium.
@nl
type
label
MRI contrast agents based on dysprosium or holmium.
@en
MRI contrast agents based on dysprosium or holmium.
@nl
prefLabel
MRI contrast agents based on dysprosium or holmium.
@en
MRI contrast agents based on dysprosium or holmium.
@nl
P1476
MRI contrast agents based on dysprosium or holmium.
@en
P356
10.1016/J.PNMRS.2010.08.002
P577
2010-09-07T00:00:00Z